Navigation Links
Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart

In a statement released by Ranbaxy Pharmaceuticals Inc (RPI), they have stated that have received the prestigious Supplier Award // from Wal-Mart, the largest chain store in the US, for outstanding performance in the first quarter of 2005. Wal-Mart Stores is a global company with more than 1.3 million associates worldwide and nearly 5,000 stores and wholesale clubs across 10 countries.

RPI is based in Jacksonville, Florida, USA and works as a wholly owned subsidiary of Ranbaxy Laboratories, India’s largest pharmaceutical company and is mainly engaged in the sale and distribution of generic and branded prescription products in the US healthcare system. RPI had received this commendation for consistency of products and programmes provided to Wal-Mart.

Officials at Wal- mart have been quoted as saying that ‘‘Ranbaxy Pharmaceuticals Inc (RPI) has been outstanding in meeting the criteria for this award, because of the improvement in areas of on-time shipping, performance, innovative programs and partnership “.

Executive Director of Sales for RPI , Bill Winter has said that the award is something everyone at Ranbaxy has worked very hard to achieve and that all members of the team should be very proud of the accomplishment. He also said that in the future Ranbaxy would continue to focus on R&D promising to make significant progress in New Drug Discovery Research.

Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy opens Drug discovery centre in Gurgaon
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. SRL Ranbaxy offers quicker bird flu diagnostic test
9. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium
Post Your Comments:

(Date:11/30/2015)... Ill. (PRWEB) , ... November 30, 2015 , ... ... Decision Support Solutions, announced at the Radiology Society of North America (RSNA) annual ... have seen over 60% growth from 2014. Throughout 2015, the company has ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone will experience ... friend, or animal pass away, death lives among us. It is your perspective, however, ... a family of 11 children, author T Sky understands that she may see death ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case ... from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint Health ...
(Date:11/30/2015)... , ... November 30, 2015 , ... The successful filing ... pharmaceutical company. Because it is so important to this key industry segment, Regis Technologies ... your IND Filing” on December 4th at 11am EST. , Federal law does not ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... December 3, 2015. TIME: 3:15p.m. ET LINK: ... --> DATE: Thursday, December ... --> --> This will ... to ask the company questions in real-time - both in ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
(Date:11/30/2015)... , November 30, 2015 PFE ... at up to 10 G protein-coupled receptor (GPCR) targets ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> Heptares Therapeutics ("Heptares"), ... and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE ...
Breaking Medicine Technology: